These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. Aigner A. J Biotechnol; 2006 Jun 25; 124(1):12-25. PubMed ID: 16413079 [Abstract] [Full Text] [Related]
3. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Takahashi Y, Nishikawa M, Takakura Y. Adv Drug Deliv Rev; 2009 Jul 25; 61(9):760-6. PubMed ID: 19386274 [Abstract] [Full Text] [Related]
4. Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials. Thomas M, Greil J, Heidenreich O. Acta Pharmacol Sin; 2006 Mar 25; 27(3):273-81. PubMed ID: 16490161 [Abstract] [Full Text] [Related]
5. RNA interference (RNAi) in hematology. Scherr M, Steinmann D, Eder M. Ann Hematol; 2004 Jan 25; 83(1):1-8. PubMed ID: 14574462 [Abstract] [Full Text] [Related]
6. Potential use of RNA interference in cancer therapy. Phalon C, Rao DD, Nemunaitis J. Expert Rev Mol Med; 2010 Aug 18; 12():e26. PubMed ID: 20716384 [Abstract] [Full Text] [Related]
7. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L, Bieth A, Pillaire MJ, Cazaux C, Hoffmann JS, Couderc B, Teissié J. Gene Ther; 2007 May 18; 14(9):752-9. PubMed ID: 17344906 [Abstract] [Full Text] [Related]
8. RNA interference and its current application in mammals. Shen WG. Chin Med J (Engl); 2004 Jul 18; 117(7):1084-91. PubMed ID: 15265387 [Abstract] [Full Text] [Related]
9. RNA interference for the identification of disease-associated genes. Nencioni A, Sandy P, Dillon C, Kissler S, Blume-Jensen P, Van Parijs L. Curr Opin Mol Ther; 2004 Apr 18; 6(2):136-40. PubMed ID: 15195924 [Abstract] [Full Text] [Related]
10. RNA interference: a novel and physiologic mechanism of gene silencing with great therapeutic potential. Calderón AJ, Lavergne JA. P R Health Sci J; 2005 Mar 18; 24(1):27-33. PubMed ID: 15895874 [Abstract] [Full Text] [Related]
11. [Great potential of small RNAs: RNA interference and microRNA]. Vázquez-Ortiz G, Piña-Sánchez P, Salcedo M. Rev Invest Clin; 2006 Mar 18; 58(4):335-49. PubMed ID: 17146945 [Abstract] [Full Text] [Related]
12. Prospects of RNA interference therapy for cancer. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, Wu TC. Gene Ther; 2006 Mar 18; 13(6):464-77. PubMed ID: 16341059 [Abstract] [Full Text] [Related]
13. siRNA-based approaches in cancer therapy. Devi GR. Cancer Gene Ther; 2006 Sep 18; 13(9):819-29. PubMed ID: 16424918 [Abstract] [Full Text] [Related]
14. RNAi: a novel antisense technology and its therapeutic potential. Dallas A, Vlassov AV. Med Sci Monit; 2006 Apr 18; 12(4):RA67-74. PubMed ID: 16572063 [Abstract] [Full Text] [Related]
15. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Akhtar S, Benter I. Adv Drug Deliv Rev; 2007 Mar 30; 59(2-3):164-82. PubMed ID: 17481774 [Abstract] [Full Text] [Related]
17. RNAi in functional genomics. Scherr M, Eder M. Curr Opin Mol Ther; 2004 Apr 30; 6(2):129-35. PubMed ID: 15195923 [Abstract] [Full Text] [Related]
18. [RNA interference and its possible use in cancer therapy]. Ait-Si-Ali S, Guasconi V, Harel-Bellan A. Bull Cancer; 2004 Jan 30; 91(1):15-8. PubMed ID: 14975801 [Abstract] [Full Text] [Related]
19. RNA interference: potential therapeutic targets. Jana S, Chakraborty C, Nandi S, Deb JK. Appl Microbiol Biotechnol; 2004 Nov 30; 65(6):649-57. PubMed ID: 15372214 [Abstract] [Full Text] [Related]
20. The silent treatment: RNAi as a defense against virus infection in mammals. van Rij RP, Andino R. Trends Biotechnol; 2006 Apr 30; 24(4):186-93. PubMed ID: 16503061 [Abstract] [Full Text] [Related] Page: [Next] [New Search]